NCT05676619

3D Foot Scanner Reliability for Footwear Fit and Design

Reliability of 3D Foot Scanner for Use in Diabetes Fit Evaluation and Footwear Design
University of Leicester·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Diabetes Complications
Drug/Device/Intervention
3D foot scanner
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Leicester
Timeline & enrollment
Phase
N/A
Start date
Jan 31, 2023
End date
Jul 31, 2023
Enrollment
20 participants
Primary outcome

Intrarater reliability (Intraclass Correlation Coefficient) of 3D foot scans repeated at baseline (change),Interrater reliability (Intraclass Correlation Coefficient) of 3D foot scans repeated at baseline (change)

Summary

The investigators will carry out a proof-of-concept study in 20 adult healthy male and female
 volunteers in order to: assess a 3D foot scanner's reliability. Specifically, the
 investigators will assess its variability during repeated foot scans of the same subject's
 foot. Three repeated foot scans will be carried out by two different examiners to measure
 intrarater and interrater reliability (Intraclass Correlation Coefficient

ICD-10 classifications
Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05676619
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05676619 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Leicester and is currently Not yet recruiting. The study focuses on Diabetes Complications. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.